NCT05309239 is a clinical trial of ROX index in Rox Index, sponsored by Assiut University.

Who is sponsoring NCT05309239?

NCT05309239 is sponsored by Assiut University.

What drugs are being tested in NCT05309239?

Interventions in NCT05309239: ROX index.

Is NCT05309239 still recruiting?

NCT05309239 is currently status unknown. Last updated 4 April 2022.

Last reviewed 2022-04-04 · How we verify

NCT05309239

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

ROX Index in Acute Respiratory Failure

Status unknown Last updated 4 April 2022

What this trial tests

trial testing ROX index in Rox Index in 100 participants. Status unknown.

Timeline

21 March 2022

Primary endpoint
1 April 2023

1 March 2024

Quick facts

Lead sponsor	Assiut University
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	21 March 2022
Primary completion	1 April 2023
Estimated completion	1 March 2024
Sites	1 location across Egypt

Drugs / interventions tested

ROX index

Conditions studied

Rox Index — all drugs for Rox Index →

Sponsor

Assiut University

Who can join

Adults 18 to 60, any sex, with Rox Index. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

evaluation of ROX index among ICU patients to evaluate the success of non invasive ventilation or the need for intubation

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05309239 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 4 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05309239.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing